Iran Press/ Iran News: Mohammad-Hassan Fallah-Mehrabadi said on Thursday that the process of production and human trials of the Iranian COVID vaccine 'Razi Cov Pars' had been going well.
He noted that the necessary plans had been made to make this Iranian product available to the public in the shortest possible time.
The clinical trial of the 'Razi Cov Pars' vaccine, which is the first injectable-inhaled vaccine of recombinant protein in the world, began on two volunteers on February 28 in the presence of a group of officials and researchers at Rasoul Akram Hospital in Tehran.
214/209
Read more:
Iran's Razi Cov Pars vaccine, 1st inhaled vaccine in world
Volunteers get 'Razi Cov Pars' intranasal spray
